Topical Drug Delivery Market

Topical Drug Delivery Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS11105
Available Format:
Category : Healthcare

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Product Type

1.3.2. Market Segmentation by Route of Administration

1.3.3. Market Segmentation by Indication

1.3.4. Market Segmentation by End User

1.3.5. Market Segmentation by Geography

1.3.6. Analysis Period

1.3.7. Market Data Reporting Unit Value

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents By region By industry participants By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Product Type Formulation Semi-solids Ointments Creams Gels Lotions Pastes Liquids Suspensions Solutions Solids Powders Suppositories Devices (transdermal drug delivery) Patches Gels

4.1.2 Overview by Route of Administration Skin Ophthalmic Rectal Vaginal Nasal

4.1.3 Overview by Indication Acne Anesthetics Psoriasis Dermatitis & atopic dermatitis Rosacea Onychomycosis Alopecia Actinic keratosis Others

4.1.4 Overview by End User Hospitals and private clinics Home care settings Diagnostic centers Others

4.2 Market Dynamics

4.2.1 Trends

4.2.2 Drivers Impact analysis of drivers on market forecast

4.2.3 Restraints Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.3 Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Product Type

5.1. Formulation

5.1.1. Semi-solids Ointments Creams Gels Lotions Pastes

5.1.2. Liquids Suspensions Solutions

5.1.3. Solids Powders Suppositories

5.2. Devices (Transdermal Drug Delivery)

5.2.1. Patches

5.2.2. Gels

Chapter 6. Market Size and Forecast by Route of Administration

6.1. Skin

6.2. Ophthalmic

6.3. Rectal

6.4. Vaginal

6.5. Nasal

Chapter 7. Market Size and Forecast by Indication

7.1. Acne

7.2. Anesthetics

7.3. Psoriasis

7.4. Dermatitis & Atopic Dermatitis

7.5. Rosacea

7.6. Onychomycosis

7.7. Alopecia

7.8. Actinic Keratosis

7.9. Others

Chapter 8. Market Size and Forecast by End User

8.1. Hospitals and Private Clinics

8.2. Home Care Settings

8.3. Diagnostic Centers

8.4. Others

Chapter 9. Market Size and Forecast by Geography

9.1. North America Topical Drug Delivery Market

9.1.1. By Product Type

9.1.2. By Route of Administration

9.1.3. By Indication

9.1.4. By End User

9.1.5. By Country – The U.S. and Canada

9.2. Europe Topical Drug Delivery Market

9.2.1. By Product Type

9.2.2. By Route of Administration

9.2.3. By Indication

9.2.4. By End User

9.2.5. By Country – The U.K., Germany, France, Italy, Spain, and Rest of Europe

9.3. Asia-Pacific Topical Drug Delivery Market

9.3.1. By Product Type

9.3.2. By Route of Administration

9.3.3. By Indication

9.3.4. By End User

9.3.5. By Country – Japan, China, India and Rest of Asia-Pacific

9.4. Latin America Topical Drug Delivery Market

9.4.1. By Product Type

9.4.2. By Route of Administration

9.4.3. By Indication

9.4.4. By End User

9.4.5. By Country – Brazil, Mexico and Rest of Latin America

9.5. Middle East & Africa Topical Drug Delivery Market

9.5.1. By Product Type

9.5.2. Route of Administration

9.5.3. By Indication

9.5.4. By End User

9.5.5. By Country – South Africa and Rest of Middle East and Africa

Chapter 10. Competitive Landscape

10.1. Competitive Analysis of Key Players

10.2. Global Strategic Developments

Chapter 11. Company Profiles

11.1. GlaxoSmithKline PLC

11.1.1. Business Overview

11.1.2. Product and Service Offerings

11.1.3. Strategic Growth Plan

11.2. Janssen Global Services, LLC. (Johnson and Johnson)

11.2.1. Business Overview

11.2.2. Product and Service Offerings

11.2.3. Strategic Growth Plan

11.3. Novartis International AG

11.3.1. Business Overview

11.3.2. Product and Service Offerings

11.3.3. Strategic Growth Plan

11.4. Bayer AG

11.4.1. Business Overview

11.4.2. Product and Service Offerings

11.4.3. Strategic Growth Plan

11.5. Cipla Limited

11.5.1. Business Overview

11.5.2. Product and Service Offerings

11.5.3. Strategic Growth Plan

11.6. Galderma S.A

11.6.1. Business Overview

11.6.2. Product and Service Offerings

11.6.3. Strategic Growth Plan

11.7. Sienna Biopharmaceuticals, Inc.

11.7.1. Business Overview

11.7.2. Product and Service Offerings

11.7.3. Strategic Growth Plan

11.8. Allergan PLC.

11.8.1. Business Overview

11.8.2. Product and Service Offerings

11.8.3. Strategic Growth Plan

11.9. Crescita Therapeutics Inc.

11.9.1. Business Overview

11.9.2. Product and Service Offerings

11.9.3. Strategic Growth Plan

11.10. SOLVAY S.A.

11.10.1. Business Overview

11.10.2. Product and Service Offerings

11.10.3. Strategic Growth Plan

*Note: Strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 12. Appendix

12.1. Abbreviations

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry